Cargando…
A practical approach to communicating benefit-risk decisions of medicines to stakeholders
Purpose: The importance of a framework for a systematic structured assessment of the benefits and risks has been established, but in addition, it is necessary that the benefit-risk decisions and the processes to derive those decisions are documented and communicated to various stakeholders for accou...
Autores principales: | Leong, James, Walker, Stuart, Salek, Sam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4463867/ https://www.ncbi.nlm.nih.gov/pubmed/26124720 http://dx.doi.org/10.3389/fphar.2015.00099 |
Ejemplares similares
-
Strategy for communicating benefit-risk decisions: a comparison of regulatory agencies' publicly available documents
por: Leong Wai Yeen, James, et al.
Publicado: (2014) -
Can Standardisation of the Public Assessment Report Improve Benefit-Risk Communication?
por: Keyter, Andrea, et al.
Publicado: (2020) -
The Reliability and Relevance of a Quality of Decision Making Instrument, Quality of Decision-Making Orientation Scheme (QoDoS), for Use During the Lifecycle of Medicines
por: Bujar, Magdalena, et al.
Publicado: (2019) -
Evaluating Quality of Decision-Making Processes in Medicines' Development, Regulatory Review, and Health Technology Assessment: A Systematic Review of the Literature
por: Bujar, Magdalena, et al.
Publicado: (2017) -
The Development and Validation of a Generic Instrument, QoDoS, for Assessing the Quality of Decision Making
por: Donelan, Ronan, et al.
Publicado: (2016)